Most Recent
The High Court has rejected an appeal challenging a ruling that found a failed political candidate liable for defamatory responses made by readers of two Facebook posts he published that labelled a South Australian businessman greedy and selfish, but the court has left the door open to weigh in on the issue of secondary publication of social media comments.
Two casinos owned by Crown Resorts have been handed a Federal Court victory in their $100 million battle with the Australian Taxation Office, with a judge ruling that GST assessments made by the ATO were "excessive".
The judge overseeing a class action against GetSwift has refused to disqualify himself from the proceedings, rejecting claims that he could not be seen to approach the case with an "impartial mind" and taking a passing shot at the logistics company's use of the Americanism "recuse" in its application.
A high ranking executive from the Commonwealth Bank of Australia has warned that an increase in class actions could discourage Australia's best corporate leaders from joining company boards.
A recent announcement by logistics tech provider GetSwift that it will be relocating to Canada has heightened concerns by the lawyers running a shareholder class action against the company that it might not be able to meet any orders for compensation to group members.
App stores have become the latest battleground in the the Australian Competition and Consumer Commission's investigation into digital platforms, with the regulator promising to look at data sharing practices, pricing and competition between Google and Apple, the two biggest players in the market.
An appeals court has dealt with complex jurisdiction and limitations issues in transferring one of three class actions against ride sharing giant Uber to another court, with one of the judges saying legislative reforms were needed to deal with the issues.
An IOOF subsidiary sued over "bad advice" has failed in its bid to stop ASIC from using documents from the banking royal commission as evidence in the case, with a judge saying the company had already provided the material to the financial watchdog without objection.
US pharmaceutical giant Merck Sharp & Dohme has taken a unit of Indian generic manufacturer Lupin to court for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Januvia and Janumet.
A class action has been filed against the Commonwealth Bank of Australia over commissions grandfathered by the Future of Financial Advice reforms.